Company Overview and News

 
CapitaLand Bouncing Back On Renewed Asset Recycling

2018-09-25 seekingalpha
CapitaLand has stepped up its asset recycling efforts, including a sizable investment into U.S. West Coast multi-family housing.
U14 C09 UOLGF WKSGY CDEVF UOLGY CDEVY CLLDY

 
Singapore's packed property showrooms not indicative of real demand

2018-07-24 malaymail
SINGAPORE, July 24 — Lured by discounts offered by developers, thousands of prospective home buyers flocked to the preview of two private property projects over the weekend, in spite of the latest round of property cooling measures introduced barely two weeks ago.
U14 UOLGF UOLGY

 
UOL acquires 180 apartments in Jakarta for S$76.3m; inks agreement to operate PARKROYAL Jakarta

2018-07-17 theedgemarkets
SINGAPORE (July 16): UOL Group announced that its indirect wholly-owned subsidiary in Indonesia, PT Success Venture Serviced Suited Investments, is acquiring 180 apartments and ancillary facilities at Thamrin Nine’s Tower 2 in Jakarta, Indonesia for US$56.2 million from Putragaya Wahana.
U14 UOLGF UOLGY

 
Singapore developers attack cooling measures, Straits Times says

2018-07-07 malaymail
SINGAPORE, July 7 — A leading developers’ group in Singapore has challenged the government’s latest round of property-cooling measures, saying that there’s no rationale for the steps as the market is only in the early stages of a recovery, the Straits Times reported, citing a statement from the group.
U14 C09 UOLGF CDEVF UOLGY CDEVY

5
Singapore announces surprise property curbs to cool market

2018-07-06 malaymail
SINGAPORE, July 6 — Singapore’s renewed clampdown on speculative property demand sent real estate stocks reeling today, as analysts predicted the end of a nascent home price rebound and the deflation of a buoyant market for collective sales.
5UX CDEVY WTHEF D05 C09 DBSDF UOLGF UOVEF DBSDY U14 C UOLGY O39 U11 CGBBW UOVEY CDEVF KPPLF

 
Fall ahead of U.S. tariffs; Singapore sinks to 14-month low

2018-07-06 theedgemarkets
(July 6): Southeast Asian stock markets fell on Friday, as investors closed positions and waited anxiously for the impending tariffs on Chinese imports by U.S. President Donald Trump, with Singapore falling more than 2% to a 14-month low.
U14 C09 UOLGF CDEVF UOLGY CDEVY

1
Singapore's Decisive Property Crackdown Set to Damp `Euphoria'

2018-07-06 theedgemarkets - 1
(July 6): Singapore’s surprise crackdown to drive out speculative investments from the property market will probably hit collective sales that had become popular with developers of late, sending stocks reeling.
UOVEF 5UX DBSDY U14 5H0 UOLGY CDEVY U11 O39 WTHEF D05 C09 DBSDF UOLGF UOVEY CDEVF KPPLF

 
Singapore’s decisive property crackdown set to damp ‘euphoria’

2018-07-06 thestar.com.my
SINGAPORE: Singapore’s surprise crackdown to drive out speculative investments from the property market will probably hit collective sales that had become popular with developers of late, sending stocks reeling. The tightened rules, rolled out a day after the central bank noted “euphoria” in the property market, sharply increase buyers’ stamp duties for entities such as developers. Singapore’s benchmark Straits Times Index dropped as much as 2.
UOVEF 5UX DBSDY U14 5H0 UOLGY CDEVY U11 O39 WTHEF D05 C09 DBSDF UOLGF UOVEY CDEVF KPPLF

 
Singapore’s decisive property crackdown set to damp 'euphoria’

2018-07-06 malaymail
SINGAPORE, July 6 — Singapore’s surprise crackdown to drive out speculative investments from the property market will probably hit collective sales that had become popular with developers of late, sending stocks reeling.
UOVEF 5UX DBSDY U14 5H0 UOLGY CDEVY U11 O39 WTHEF D05 C09 DBSDF UOLGF UOVEY CDEVF KPPLF

 
Singapore Developer Stocks Fall After Surprise Property Curbs

2018-07-06 theedgemarkets
(July 6): Singapore property and bank stocks led declines on the benchmark stock index Friday after the government unexpectedly tightened property curbs to cool a market the central bank described as euphoric. City Developments Ltd. and UOL Group Ltd. fell more than 14 percent each.
UOVEF 5UX DBSDY U14 5H0 UOLGY CDEVY U11 O39 WTHEF D05 C09 DBSDF UOLGF UOVEY CDEVF KPPLF

 
Property stocks slump after announcement of new cooling measures

2018-07-06 channelnewsasia
SINGAPORE: Property stocks in Singapore came under heavy selling in early trade on Friday (Jul 6), as investors reacted to surprise news of fresh cooling measures announced a day earlier.
U14 C09 UOLGF CDEVF UOLGY CDEVY

 
Philippines sheds over 1%; others wary before U.S. tariff deadline

2018-07-05 theedgemarkets
(July 5): Philippine shares fell more than 1% on Thursday, after the country's June inflation hit an over five-year high, while other markets in the region were subdued on caution ahead of Friday's deadline for further U.S. tariffs on Chinese goods.
SMIVY U14 SVTMF UOLGF SGAPY SM UOLGY COL SNGNF

2
Commentary: Higher buyer’s stamp duty a wealth tax with mixed impact on the property market - Channel NewsAsia

2018-03-24 channelnewsasia - 2
The higher buyer’s stamp duty may jolt property prices, says director of the Institute of Real Estate Studies at the National University of Singapore.
U14 UOLGF UOLGY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 91529G105